Immunotherapy for the treatment of multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy for the treatment of multiple myeloma

Published:2017-03 Issue: Volume:111 Page:87-93
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Jung Sung-Hoon,Lee Hyun-Ju,Vo Manh-Cuong,Kim Hyeoung-Joon,Lee Je-Jung

Funder

Leading Foreign Research Institute Recruitment Program

Ministry of Education

Korea Health Technology R&D Project

Ministry of Health & Welfare

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference70 articles.

1. Remissions of multiple myeloma during a first-in-humans clinical trial of t cells expressing an anti-B-Cell maturation antigen chimeric antigen receptor;Ali;Blood,2015

2. T cells expressing an anti-B-cell-maturation-antigen chimeric antigen receptor cause remissions of multiple myeloma;Ali;Blood,2016

3. A phase II study of anti PD-1 antibody pembrolizumab, pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM);Badros;Blood,2015

4. Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders;Bae;Clin. Cancer Res.,2012

5. Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens;Bellucci;Blood,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring cellular immunotherapy platforms in multiple myeloma;Heliyon;2024-03

2. Immune checkpoint inhibitors for multiple myeloma immunotherapy;Experimental Hematology & Oncology;2023-11-28

3. Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review;Diagnostics;2023-07-10

4. A Dendrimer Peptide (KK2DP7) Delivery System with Dual Functions of Lymph Node Targeting and Immune Adjuvants as a General Strategy for Cancer Immunotherapy;Advanced Science;2023-03-22

5. Exploring Cellular Immunotherapy Platforms in Multiple Myeloma;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3